Ticker League

Revenue for Regeneron Pharmaceuticals (REGN)

Latest filings through · Reported

Metric

TTM

$14.92B

YoY change

+1.0%

5Y CAGR

+11.0%

Peak year (2021)

$16.07B

Revenue history chart for Regeneron Pharmaceuticals (REGN) from 1990 to 2025

Latest: $14.34B

Revenue growth chart for Regeneron Pharmaceuticals (REGN) from 1990 to 2025

Latest: +1.0%

Revenue history table for Regeneron Pharmaceuticals (REGN) from 1990 to 2025

  • 2025$14.34B+1.0%
  • 2024$14.20B+8.3%
  • 2023$13.12B+7.8%
  • 2022$12.17B-24.3%
  • 2021$16.07B+89.1%
  • 2020$8.50B+29.6%
  • 2019$6.56B-2.3%
  • 2018$6.71B+14.3%
  • 2017$5.87B+20.8%
  • 2016$4.86B+18.4%
  • 2015$4.10B+45.5%
  • 2014$2.82B+34.0%
  • 2013$2.10B+52.7%
  • 2012$1.38B+209.2%
  • 2011$445.82M-2.9%
  • 2010$459.07M+21.0%
  • 2009$379.27M+59.1%
  • 2008$238.46M+90.7%
  • 2007$125.02M+97.1%
  • 2006$63.45M-4.1%
  • 2005$66.19M-62.0%
  • 2004$174.02M+202.7%
  • 2003$57.50M+161.5%
  • 2002$21.99M+0.1%
  • 2001$21.97M-62.9%
  • 2000$59.28M+71.8%
  • 1999$34.50M-9.7%
  • 1998$38.20M+15.4%
  • 1997$33.10M+37.3%
  • 1996$24.10M-12.0%
  • 1995$27.40M+18.1%
  • 1994$23.20M+118.9%
  • 1993$10.60M-7.8%
  • 1992$11.50M+57.5%
  • 1991$7.30M+46.0%
  • 1990$5.00M—

Revenue values are taken from Regeneron Pharmaceuticals's reported income statements (quarterly 10-Q and annual 10-K filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the filing date. YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.

About Revenue at Regeneron Pharmaceuticals (REGN)

According to Regeneron Pharmaceuticals's latest reported financial statements, the company's current revenue (TTM) is $14.92B. Revenue is the total income from selling goods or services before any expenses. Unlike net income (earnings), revenue does not subtract operating costs, taxes, or other charges. Figures are in USD; chart and tables below use historical filings.

Headline TTM above sums the four reported quarters through (reported ). Chart and table below cover the full reported history back to .

2025's annual revenue for Regeneron Pharmaceuticals (REGN) came in at $14.34B – edged up 1.0% year-over-year.

Through 2020–2025 (5 years), Regeneron Pharmaceuticals revenue delivered a +11.0% annualised rate; sustaining 3 straight years of year-over-year growth.

Between 2021 and 2025, Regeneron Pharmaceuticals revenue declined 10.8%, falling from $16.07B to $14.34B.

The record annual revenue stands at $16.07B, reached in 2021; the historical low of $5.00M was recorded in 1990.

Regeneron Pharmaceuticals Revenue by Year

Regeneron Pharmaceuticals Revenue 2025: $14.34B

Regeneron Pharmaceuticals revenue in 2025 was $14.34B, edged up 1.0% from 2024.

Regeneron Pharmaceuticals Revenue 2024: $14.20B

2024's revenue for Regeneron Pharmaceuticals came in at $14.20B, grew 8.3% from 2023.

Regeneron Pharmaceuticals Revenue 2023: $13.12B

Regeneron Pharmaceuticals posted revenue of $13.12B in 2023, grew 7.8% from 2022.

Regeneron Pharmaceuticals Revenue 2022: $12.17B

In 2022, Regeneron Pharmaceuticals reported revenue of $12.17B, declined 24.3% below 2021.

Regeneron Pharmaceuticals Revenue 2021: $16.07B

Regeneron Pharmaceuticals revenue in 2021 was $16.07B.

See more financial history for Regeneron Pharmaceuticals (REGN).

Sector peers by Revenue

Healthcare peers of Regeneron Pharmaceuticals (REGN), ranked by their latest revenue

Frequently asked questions

Regeneron Pharmaceuticals (REGN) Key Financials

Charts, filings, and peer comparison for every metric

Explore more

Deep-dives across the income statement, cash flow, capital return, and valuation